KITE - Kite Pharma

Industry: Biotechnology Sector: Healthcare | Exchange: NASDAQ

Buy Candidate
Buy Score Rank #1237 out of #5176
Wed 26'th Jul 2017

2017-04-27 - 2017-07-26





Request Prediction

Kite Pharma Stock Analysis

Technical stock analysis for Wed 26'th Jul 2017

Buy candidate since 2017-07-17 Gain 8.78%

Kite Pharma gained 0.65% in the last trading day, rising from $110.52 to $111.24 The price has been going up and down for this period, and there has been a 6.3% gain for the last 2 weeks. Volume fell in the last day by -41 563 shares, and in total, 851 253 shares bought and sold for approximately $94.69 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.


Kite Pharma lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 50.78% during the next 3 months and, with 90% probability hold a price between $146.77 and $182.97 at the end of this period.


Only positive signals in the chart today. Kite Pharma holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $108.93 and $99.27. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday July 25, 2017, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Relative Strength Index (RSI)

RSI14 is 64 and the stock is currently not being overbought or oversold

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $100.66 and $87.79. On the upside the stock meets some resistance just above today's level from accumulated volume at $112.98.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Kite Pharma finds support just below today's level at $100.66. If this is broken, then the next support from accumulated volume will be at $87.79 and $86.67. The stock is about to test the resistance from accumulated volume at $112.98 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $100.66 Price: $111.24 Resistance: $112.98
S: $100.66 Price: $111.24 R: $112.98


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $2.32 (2.10%) between high and low. For the last week, the stock has had a daily average volatility of 3.27%.

Our recommended stoploss: $105.27 (-5.36%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Overall risk:



Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Buy Candidate

Buy KITE Shares
Your capital is at risk.

Learn To Identify Profitable Stock Chart Patterns.

FREE 7-Day Training

Learn To Identify Profitable Stock Chart Patterns.

FREE 7-Day Training
Help StockInvest improve by answering this short survey clicking HERE.

Build Your Watchlist

Add KITE My Watchlist

books of the week

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Sign up to get FREE access to awesome features

Auto-portfolios that gain up to 30%

Request predictions from other users

Watchlist builder with notifications

News updates from 100+ financial publications